In trading on Wednesday, shares of Sarepta Therapeutics Inc (SRPT) touched a new 52-week high of $33.16/share. That's a 192.67% rise, or $21.83 per share from the 52-week low of $11.33 set back on 01/14/2015. That means at today's intraday high, any investor who purchased SRPT stock any time over the past 52 weeks has an unrealized gain, including company insiders.Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, SRPT has seen 2 different instances of insiders buying over the trailing six month period.
|02/27/2015||Edward M. Kaye, M.D.||SVP & Chief Medical Officer||800||$11.81||$9,452.00|
|02/27/2015||Nishan Garabedian Christopher||President and CEO||800||$11.81||$9,452.00|
In afternoon trading on Wednesday, SRPT shares are changing hands at $32.64/share, slightly below the new 52-week high.